medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 6

<< Back Next >>

Med Int Mex 2021; 37 (6)

Peritoneal tuberculosis in an immunocompetent patient

López CD, Ramírez MV, Cajiao-Correa G, Vargas-Rodríguez L
Full text How to cite this article

Language: Spanish
References: 16
Page: 1108-1113
PDF size: 343.95 Kb.


Key words:

Tuberculosis, Peritoneal tuberculosis, Peritoneal carcinomatosis.

ABSTRACT

Background: Tuberculosis is one of the most important communicable diseases in the world.
Clinical case: A 22-year-old male patient who consulted for a 6-month period of moderate intensity abdominal pain associated with emetic episodes, weight loss, anorexia, asthenia and adynamia. At the physical examination patient had generalized pallor, poor nutritional status, 3 cm ganglion in the left supraclavicular region, tense, painful and palpable abdomen in the epigastrium, flank and right iliac fossa, in addition to the palpable mass in the mesogastrium. The tomography showed abdominal conglomeration, and the biopsy confirmed the presence of resistant alcoholic acid bacilli, thus initiating the management of peritoneal tuberculosis with tetraconjugate.
Conclusions: Only 18% of patients with tuberculosis have extrapulmonary forms. The condition of the peritoneum occurs in only 1 to 3% of cases. There are multiple risk factors that can be associated with the development of this entity, mainly that facilitate immunodeficiency.


REFERENCES

  1. Pai M. Time for high-burden countries to lead the tuberculosis research agenda. PLoS Med 2018; 15: e1002544. doi: 10.1371/journal.pmed.1002544.

  2. Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, et al. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infec 2011; 63: 362-9. doi: 10.1016/j.jinf.2011.06.010.

  3. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49: 1350- 1357. doi: 10.1086/605559.

  4. Solier J, Bolívar A, Calvo LS, Roberto SL. Tuberculosis peritoneal simulando cáncer de ovario. Acta Médica Colomb 2014; 20 (6): 383-7. https://doi.org/10.36104/ amc.2014.312.

  5. Gomes T, Vinhas SA, Reis-Santos B, Palaci M, Peres RL, et al. Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in Brazil. PLoS One 2013; 8 (10): e74517. https://dx.doi. org/10.1371%2Fjournal.pone.0074517.

  6. García JF, Álvarez H, Lorenzo MV, Mariño A, Fernández-Rial A, et al. Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infecc Microbiol Clin 2011; 29: 502-509. doi: 10.1016/j.eimc.2011.03.005.

  7. Mimidis K, Ritis K, Kartalis G. Peritoneal tuberculosis. Ann Gastroenterol 2005; 18: 325-9.

  8. Pereira T, Wagner B, Schmaltz C, Sant’Anna F, Saad MH, Arruda J. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients. BMC Infect Dis 2017; 17: 606-616. doi: 10.1186/s12879- 017-2700-6.

  9. Lee SS, Lee CM, Kim TH, Kim JJ, Lee JM, Kim HJ, et al. Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2016; 20 (6): 800-5. doi: 10.5588/ijtld.15.0668.

  10. Mamo JP, Brij SO, Enoch DA. Abdominal tuberculosis: a retrospective review of cases presenting to a UK district hospital. QJM 2013; 106 (4): 347-54. doi: 10.1093/qjmed/ hct003.

  11. Chen HL, Wu MS, Chang WH, Shih SC, Chi H, Bair MJ. Abdominal tuberculosis in southeastern Taiwan: 20 years of experience. J Formos Med Assoc 2009; 108 (3): 195-201. doi: 10.1016/S0929-6646(09)60052-8.

  12. Pattanayak S, Behuria S. Is abdominal tuberculosis a surgical problem? Ann R Coll Surg Engl. 2015; 97 (6): 414-9. doi: 10.1308/rcsann.2015.0010.

  13. Demay C, Liens B, Burguière T, Hill V, Couvin D, et al. SITVITWEB--a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 2012; 12: 755-766. doi: 10.1016/j.meegid. 2012.02.004.

  14. Borgdorff MW, van den Hof S, Kalisvaart N, Kremer K, van Soolingen D. Influence of sampling on clustering and associations with risk factors in the molecular epidemiology of tuberculosis. Am J Epidemiol 2011; 174: 243-251. doi: 10.1093/aje/kwr061.

  15. Schmaltz CAS, Sant’Anna FM, Neves SC, Velasque LDS, Lourenço MC, Morgado MG, et al. Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro. Brazil J Acquir Immune Defic Syndr 2009; 52: 623-8. doi: 10.1097/QAI.0b013e3181b31e56.

  16. Sanai FM, Bzeiki KI. Systematic review: tuberculosis peritonitis– presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 2005; 22 (8): 685-700. doi: 10.1111/j.1365-2036.2005.02645.x.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2021;37